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ABSTRACT
Male infertility is now recognised as a significant factor in couples having
difficulty conceiving. The impact of maternal age has long been known as a
limiting factor, however recent research indicates that advancing paternal
age can also negatively impact on a couple's chances of conception. One
of the major contributing causes of male infertility has now been linked to
spermatozoa exposure to reactive oxygen species (ROS). Such exposure
induces oxidative stress when coupled with reduced total antioxidant
capacity (TAC). Measures of both ROS and TAC are used as tests of
oxidative stress status (OSS) which are used together to give further insight
into male fertility status. Current research has revealed that the level of
DNA fragmentation increases with age and, due to their composition, the
sperm plasma membrane, DNA double helix and single stranded DNA are
highly susceptible to ROS attack. ROS cause high levels of lipid
peroxidation (LPO) that ultimately damages the plasma membrane and
interferes with its vital functions. ROS also readily attack the purine and
pyrimidine bases of DNA resulting in DNA damage. It is hypothesized that
advancing paternal age will impact negatively of levels of ROS, TAC and
DNA fragmentation in ageing men. The aim of this study was to determine
the relationship between ROS, TAC and DNA damage on spermatozoon
viability in relation to age.

Ejaculated semen samples from 54 men undergoing infertility assessment
were collected and divided into men aged

~40

years (n=16) and men aged

::;;39 years (n=38). Samples were examined for their level of ROS and TAC
as a possible indication of oxidative stress status. Samples were also
assessed for DNA fragmentation and damage using TUNEL.

Statistical analysis consisted of independent t-tests, chi-square tests and
multivariate logistic regression. Analysis found no significant associations
between ROS, TAC, TUNEL and age. Significant differences were
observed between abnormal sperm motility and age (p<0.05; t-test and
2

regression analysis) and between abnormal sperm concentration and
TUNEL (p<0.05; chi-square test and regression analysis).

The results obtained in this present study did not support the hypothesis
that there is an association between age, ROS, TAG and TUNEL. Research
has identified a negative correlation between the effects of ROS and
reduced TAG and advancing age on male fertility. ROS, either alone or in
combination with reduced TAG, has also been directly associated with an
increase in DNA damage. An increase in the incidence of certain childhood
cancers and disease has been linked to spermatozoon DNA damage.
Future research should be directed toward exploring the influences of these
factors in relation to advancing paternal age given the potential benefits
extend beyond the couple and to any future offspring.
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CHAPTER 1:
LITERATURE REVIEW
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1.1 INTRODUCTION
One in seven couples has difficulty conceiving during their reproductive
lives with male factor infertility implicated ir-1 between 20-80% of these
cases (Agarwal et al., 2004; Pirrello et al., 2005; Tremellen, 2008). It has
been suggested that male subfertility is increasing (Male Infertility, 2005).
Environmental, physiological and genetic factors have all been associated
with reduced sperm function and unexplained male factor infertility (Sikka,
2001 ). The accurate identification of possible factors leading to infertility
requires vast knowledge of the conditions deemed favourable for normal
sperm development and function (Sikka, 2001 ). At present it is more
0

common for couples to delay parenthood well into their thirties, without
considering that their fertility status may be reduced to the point where
assistance is required (Lampic et al., 2006; Sloter, Schmid, Marchetti et al.,
2006; Tough et al., 2006). While the impact of age on female fertility has
long been realized (Schmid, Eskanazi et al., 2007) only now are we starting
to investigate male fertility. Advanced paternal age at the time of conception
has

now been

associated

with

a

number of diseases such

as

schizophrenia, multiple endocrine neoplasia and achondroplasia as well as
with decreased semen parameters, chromosomal abnormalities and
reduced fertility (Baker & Aitken, 2005; Lambert, Masson & Fisch, 2006;
Plastira, Msaouel, Angelopoulou et al., 2007; Schmid et al., 2007).

Aetiologies implicated in male infertility include gene mutations, aneuploidy,
infectious diseases, ejaculatory duct occlusion, varicocoele, radiation,

11

chemotherapy and erectile dysfunction (OIIero et al., 2001; Smith et al.,
2006). Whilst many of these conditions are treatable, there remain cases
where no immediate identification of the fertility problem can be made. It is
well documented that older men take longer to produce pregnancy with an
increasing proportion undergoing treatment (Ng et al., 2004). Recent
research appears to focus primarily on the effects of reactive oxygen
species (ROS), antioxidants, DNA damage and age on the fertilizing
capabilities of human spermatozoa (Ebisch et al., 2007; Plastira et al.,
2007; Tremellen, 2005).

1.1.1 Spermatozoon Anatomy
1.1.1.1 The Head
The anatomy of human sperm is presented in Figure 1. The head of the
spermatozoon is composed of a tightly condensed and compact nucleus,
containing DNA, and an acrosomal cap. The spermatozoon nucleus
undergoes

considerable

reorganisation

during the

latter stages

of

spermatogenesis where approximately 85% of nuclear histones are
replaced with nuclear protamines (Kalthoff, 2001, p.58;

Boe~Hansen

et al.,

2006). Protamines are proteins containing a high content of positively
charged amino acids (Oliva, 2006) and provide multiple functions. These
include the generation of a more condensed paternal genome resulting in a
more compact and hydrodynamic head, protection of the genome by
making it largely inaccessible to nucleases or mutagens present in the
surrounding environment and removal of epigenetic information from the
paternal

genom~

allowing for reprogramming in the oocyte. Also in some
12

unknown manner protamines participate in imprinting of the genome during
spermatogenesis (Oliva, 2006).

Another stage in spermatogenesis involves the reduction or 'pinching off' of
cytoplasm. This results in a mature spermatozoon with a characteristic
shape containing little cytoplasm.

The cytoplasm is a major reservoir of

cellular defense mechanisms and in the immature spermatozoa aids in
normal cell maintenance and function. As the majority of the cytoplasm is
removed mature spermatozoa are left with few cytoplasmic defense
mechanisms (Ebisch et al., 2007).

Figure 1 Spermatozoon Anatomy
Mature spermatozoon

l'Eill

Head

Neck

Middle piece

Principal piece

End piece

(Ref: Young & Heath. 2002)

1.1.1.2 Plasma Membrane
The plasma membrane encases the head and contains a specific
combination of phospholipids, cholesterol and proteins to ensure its optimal
functioning (Kalthoff, 2001, p58). In normal intact functional plasma
membranes

the

negatively

charged

membrane

phospholipid

phosphatidylserine (PS) is located on the inner side of the plasma
membrane. At the onset of membrane disturbance PS is translocated to the
13

outer surface of the plasma membrane (Glander & Schaller, 2000) and is
considered a marker of reduced sperm function.

1.1.1.3 The Midpiece
The midpiece of spermatozoa is rich in mitochondria and strategically
placed at the base of the tail which utilizes the majority of the ATP
generated (Kalthoff, 2001, p.58). Mitochondrial activity in the mid piece
provides the ATP required to power the tail (Martini, 2001, p.1025). As a
result of this localization the midpiece becomes more fragile and is the
major target site for damage by reactive oxygen species (ROS; see section
2).

1.1.1.4 The Tail
The tail (also known as the flagellum) consists of a principal and end piece
and works in a corkscrew motion to allow forward movement. The principal
piece is composed of an axonemal core surrounded by a fibrous sheath
and the end piece of axoneme only. The axoneme of the flagellum refers to
the 9 plus 2 arrangement of microtubules (Kalthoff, 2001, p.28-29).

1.1.2 Capacitation
Capacitation refers to a series of structural and functional changes
occurring in spermatozoa that begins after the removal of stabilizing factors,
one of which is cholesterol, from seminal plasma and ends when
spermatozoa are capable of responding to zona pellucida ligands on the
oocyte by undergoing the acrosome reaction (De Jonge, 2005). Cholesterol
within seminal plasma appears to impose a regulatory function on
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capacitation and be a major seminal plasma inhibitor. Investigations have
revealed that, on transit through the cervical mucous, the sperm plasma
membrane undergoes further remodeling and loses both cholesterol and
glycerol-phospholipids (De Jonge, 2005). Hyperactivation seems to occur
immediately prior to the acrosome reaction and describes an apparent
change in characteristic sperm motility. There is clear evidence that several
critical components need to be present for initiation and optimization of
capacitation (De Jonge, 2005).

1.1.3 Acrosome Reaction
Spermatozoa undergo the acrosome reaction in response to the zona
pellucida, the oocytes extracellular matrix (Herrero, Lamirande & Gagnon,
2003). Capacitated sperm bind, at their head and equatorial segments
(Kalthoff, 2001, p.84), by way of a sperm membrane binding site to the ZP3
glycoprotein receptor on the zona pellucida. This association triggers an
influx of calcium which amongst other functions causes the completion of
meiosis II in the oocyte and activates enzymes to accelerate protein
synthesis (Martini, 2001, p.1 067). Once bound, acrosomal vesicles are
exocytosed and digest portions of the cumulus, corona radiata and zona
pellucida. At this point reorganization of the plasma membrane allows the
fusion of the sperm and oocyte plasma membranes and aids in the
preclusion of polyspermy (Kalthoff, 2001, p. 85-93).
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1.2 REACTIVE OXYGEN SPECIES {ROS)
Reactive oxygen species or oxygen free radicals are highly reactive
compounds that contain one or more unpaired electrons. Such compounds
include superoxide anion (02 ·-), hydrogen peroxide (H 20 2), peroxyl radicals
(ROO") and hydroxyl radicals (OH") (Sikka, 2001; Tremellen, 2008;
Sanocka & Kurpisz, 2004). Tremellen (2008) points out that leukocytes and
sperm are the two primary sources of free radicals within semen.

Male germ cells at various stages produce ROS and their production is
essential at specifically controlled concentrations for normal sperm function
(Sikka, 2001). Studies have found that there is a negative association
between ROS concentration and morphology, motility, seminal plasma and
ejaculate volume, sperm vitality, membrane integrity, DNA fragmentation,
total antioxidant concentration (TAC) and fertilization rate (Ebisch et al., GiiGuzman et al., 2001; 2007; Hammadeh et al., 2006; Lopes et al., 1998).

Immature spermatozoa show excessive ROS production, which is directly
associated with QNA damage in mature spermatozoa (Hammadeh et al.,
2006; Moustafa et al., 2004). Both superoxide and the hydroxyl radical
(OH"), being the most toxic ROS (Sikka, 2001), are mutagenic. ROS
production is highest in immature spermatocytes and lowest in mature
spermatozoa and

immature germ cells (Gii-Guzman et al., 2001).

Leukocyte production of ROS in seminal plasma is also of importance as
they have been reported to produce anywhere from 100- to 1000- fold
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higher amounts than that of spermatozoa even at capacitation (Moustafa et
al., 2004; Tremellen, 2008)

It is becoming increasingly apparent that spermatozoa ROS production is
significant in the aetiology of infertility. Both ROS produced by leukocytes
and spermatozoa impose a negative effect on sperm DNA integrity
however, it is the ROS produced by spermatozoa that is the most
significant (Tremellen, 2008). This is believed to be a result of the close
proximity between the ROS production and sperm DNA. Free radicals
attack the purine and pyrimidine bases and deoxyribose backbone of the
DNA double helix (Tremellen, 2008). The primary mode of action of ROS is
believed to be a rapid loss in intracellular ATP resulting in axonemal
damage and reduced sperm motility.

Hydrogen peroxide (H 2 0 2 ) is the

primary reactive oxygen species (ROS) to interact with mitochondrial ATP
generation (Sikka, 2001 ). The inhibition of sperm mitochondrial function in
semen samples from infertile patients containing high superoxide levels has
been observed (Sikka, 2001). Interference with plasma membrane function
via peroxidaHon ofunsaturated fatty acids is believed to be another mode of
action. Due to the pivotal role of the plasma membrane this interference
renders the sperm dysfunctional (Donnelly et al., 1999; Ebisch et al., 2007;
Sikka, 2001; Tavilani et al., 2008).

ROS are involved in the processes of sperm capacitation, hyperactivation,
acrosome reaction (Lopes et al., 1998) and fertilization (Agarwal et al.,
2004; Gii-Gulman et al., 2001). Hydrogen peroxide stimulates the
17

acrosome reaction and hyperactivation of sperm and is also important in
low levels for sperm-oocyte fusion (Tremellen, 2008). Further to this,
abnormally high ROS production interferes with sperm-zona pellucida
binding, sperm-oocyte fusion (Appasamy et al., 2007; Tremellen, 2008) and
the capacity to regulate intracellular calcium levels (Barroso et al., 2000).

1.2.1 Lipid Peroxidation
The plasma membrane is rich in polyunsaturated fatty acids (PUFA) and
therefore susceptible to ROS attack resulting in lipid peroxidation (LPO)
(Ebisch et al., 2007; Sanocka & Kurpisz, 2004; Sikka, 2001; Tremellen,
2008). Oocosahexaenoic acid (DHA) is a major PUFA in spermatozoa and
accounts for as much as 30% of phospholipid bound fatty acid and 73% of
PUFA (OIIero et al., 2001; Sanocha & Kurpisz, 2004). DHA aids in
maintaining membrane fluidity and is the main substrate for LPO. The
amounts of DHA and cholesterol are reduced during spermatogenesis
which may be an important modification in reducing the susceptibility of
mature spermatozoa to oxidative damage (OIIero et al., 2001). The
significance of this appears to be that the optimal level of DHA is retained
so as to both optimize membrane fluidity and protect against oxidative
damage (OIIero et al., 2001; Sanocka & Kurpisz, 2004).

The plasma membrane increases its permeability to electrolytes as a result
of reduced membrane integrity from LPO. Essential reactions involved in
LPO are catalysed by the presence of iron and copper ions. Membrane
damage appears to be the most evident consequence of free radical
18

damage on sperm viability (Donnelly et al., 1999). The two most common
pathways of LPO are non-enzymatic and enzymatic. Enzymatic LPO is both
NADPH and ADP dependent (Sikka, 2001 ).

Lipid peroxidation of PUFA following exposure to oxidative stress (OS)
results in a notable decline in sperm motility (Hammadeh et al., 2006).
Vitamin E terminates lipid peroxidation chain reactions and vitamin C acts
to also prevent oxidative damage to sperm DNA (Ford & Whittington, 1998).

1.3 ANTIOXIDANTS
The majority of vital antioxidant defense systems are present in sperm,
however their effects are limited due to their minimal concentration. As
sperm have been stripped of vigorous protective mechanisms against
oxidative agents, spermatozoa are particularly vulnerable to peroxidative
damage (Smith et al., 1996).

Antioxidant defense systems consist of both enzymatic and non-enzymatic
components (Tremellen, 2008). Enzymatic antioxidants include superoxide
dismutase

(SOD),

catalase,

glutathione peroxidase,

and

reductase

(Agarwal et al., 2004; Sikka, 2001; Tremellen, 2008). SOD and catalase
both inactivate the superoxide anion (02 ·-) and hydrogen peroxide (H202).
Washed sperm appear to be more susceptible to toxic oxygen metabolites
indicating a protective effect of seminal plasma on sperm integrity. Studies
have revealed that semen samples from subfertile men exhibit lower
antioxidant capacity and value than that of fertile men, confirming an
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inverse relationship between antioxidant capacity and LPO exists (Smith et
al., 1996).

There are many components of the non-enzymatic antioxidant defense
systems. They include ascorbate (vitamin C), urate, a-tocopherol (vitamin
E), pyruvate, albumins, 13-carotene, ubiquinol, glutathione, amino acids
taurine

and

hypotaurine,

carnitine,

carotenoids,

flavenoids

and

prostasomes (Smith et al., 1996; Tremellen, 2008). These are all found in
seminal plasma and act as scavengers of free radicals. Vitamin E is a major
chain breaking antioxidant found in the sperm plasma membrane and
suppresses LPO in a dose dependent manner. Albumin does not prevent
LPO, only neutralizes lipid peroxides by being oxidized itself (Twigg et al.,
1998; Tremellen, 2008; Aitken & Krausz, 2001 ). Prostasomes are
extracellular organelles that are secreted by the prostate with one of their
functions being fusion with leukocytes in the ejaculate to reduce their
production of ROS (Tremellen, 2008). Observations also indicate that ROS
production is dependent on NADPH. Not only does ROS generation by
NADPH encourage LPO but also results in a marked increase in DNA
damage. Albumin specifically reacts with peroxyl radicals and aids the
slowing of peroxidative damage (Agarwal et al., 2004; Tremellen, 2008). At
certain levels SOD enzymes hasten the removal of superoxide limiting their
detrimental effects. Several studies have concluded that NADPH may serve
as a substrate for SOD production in spermatozoa (Twigg et al., 1998).

20

Total antioxidant capacity (TAC) is a measure of oxidative stress status
(OSS). As antioxidants react with free radicals to neutralize their effect, an
excessive amount of ROS production diminishes antioxidant capacity
resulting in oxidative stress (OS). Ford & Whittington (1998) note the TAG
of seminal plasma is lower in subfertile men as opposed to fertile men.
Aitken and Krausz (2001) further this by affirming an inverse correlation
between fertility status and TAG exists. Treatment with antioxidant
supplementation assists in cases where reduced TAG is the cause however
antioxidant therapy appears to work within, at present, undefined limits
(Tarin et al., 1998; Donnelly et al., 1999). At lower concentrations they
protect against cellular damage and are even necessary for normal
function, however at higher concentrations antioxidants add to cellular
attack, dysfunction and pathological states (Sikka, 2001 ).

1.3.1 Oxidative Stress
Oxidative stress (OS) is a condition associated with the overproduction of
ROS induced by oxygen and oxygen derived oxidants (Sikka, 2001 ). It is
increased by both a rise in ROS production and a reduction of cellular
antioxidant capacity and is a key player in the aetiology of abnormal sperm
function through mechanisms involving peroxidative damage to the plasma
membrane (Twigg et al., 1998). OS is also known to affect the sperm
genome by causing high frequencies of single and double DNA strand
breaks (Hammadeh et al., 2006; Twigg et al., 1998).
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Sperm are extremely susceptible to OS as a result of their capacity to yield
ROS and the high content of polyunsaturated fatty acids in their plasma
membrane (Donnelly et al., 1999; Hammadeh et al., 2006; Smith et al.,

1996). Hz0 2 is a relatively stable ROS that readily crosses plasma and
nuclear membranes. Peroxide derived ROS readily reacts with transition
metals such as iron and copper that are abundant in normal biological
processes. This results in altered signaling and tissue injury repair
processes, consequently inducing cellular damage from the catalysis of the
lipid peroxidation cascade (Aitken & Krausz, 2001). Nitric oxide (NO) has
been shown to regulate several functions in the male reproductive tract and
at differing concentrations has opposing effects on sperm motility. At lower
concentrations it is proposed to play a role in sperm hyperactivation but at
higher concentrations of NO can inhibit sperm motility (Sikka, 2001;
Herrero, De Lamirande & Gagnon, 2003).

1.4 DNA DAMAGE
For the accurate transmission of genetic material it is essential that sperm
DNA be of highest quality. In the last stages of spermatogenesis the
nucleus is condensed and the distinctive shape of the sperm head is
formed. The ability of mature sperm to undergo DNA repair is greatly
diminished (Boe-Hansen et al., 2006; Donnelly et al., 1999) as is their
ability to undergo programmed cell death. The long term effect of DNA
damage is dependent not only on the extent and location of the damage but
also on the ability of the oocyte or even early embryo to repair the damage
(Boe-Hansen etal., 2006; Ollero et al., 2001; Plastira, 2007).
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Immature spermatozoa exhibit increased DNA damage, alterations in
protamination, chromatin packaging and excessive ROS production.
Nuclear alterations observed in spermatozoa from infertile patients include
abnormal

chromatin

structure,

microdeletions,

chromosomal

rearrangements, aneuploidy and DNA strand breaks (Barroso et al., 2000;
Moustafa et al., 2004). Aitken and Krausz (2001) remark that both
mutagenic and promutagenic changes in the sperm genome have been
extensively associated with advancing paternal age. Sperm function and
infertility are closely linked to DNA damage. It is well established that
infertile men exhibit increased chromosomal abnormalities (Black et al.,
2000), however the source of such damage is the cause of much
deliberation. A common supposition is that defective apoptosis may
account for a remarkable percentage of spermatozoa with DNA damage.
Both superoxide and OH" are known to induce chromosome deletions,
dicentrics and sister chromatid exchanges (Donnelly et al., 1999). DNA
damage has been well linked to poor pregnancy outcome (Lambert,
Masson & Fisch, 2006). Moustafa et al. (2004) and Aitken and Krausz
(2001) present several hypotheses to explain the source of DNA damage in
sperm. Firstly that it may be the result of improper packaging and ligation
during spermiogenesis secondly, as a result of OS and finally it may be a
side effect of apoptosis.
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1.4.1 Apoptosis
Programmed cell death or apoptosis is essential for tissue remodeling. It is
a normal process that occurs within somatic cells as well as amongst
different sub-populations of spermatozoa where it plays a role in regulating
sperm concentration, release and the elimination of defective spermatozoa
(Ebisch et al., 2007; Ford, 2001). Abnormal apoptotic processes have been
related to selected cases of infertility such as oligozoospermia and sperm
dysfunction. Appasamy et al. (2007) note that OS is a mediator of apoptosis
aiding in the removal of defective cells.

The presence of DNA nicks in spermatozoon could be a result of
incomplete apoptosis. Expression of Fas, a cell surface protein, is higher in
infertile men than men with normal semen parameters and believed to be
associated with apoptosis (Moustafa et al., 2004). Fas expression on the
plasma membrane is increased during the early stages of apoptosis. The
inefficient removal of such marked cells in the male reproductive tract
results in their presence in the ejaculate where they amplify ROS exposure
to mature spermatozoa. In turn this damages both mitochondrial and
nuclear membranes (Piastira et al., 2007; Schmid, Eskanazi et al., 2007)
diminishing DNA protection. New diagnostic methods are now revealing
that advancing paternal age is commonly associated with many autosomal
dominant disorders such as

achondr~plasia,

Aperts syndrome (Schmid,

Eskanazi et al., 2007), Marfan syndrome and osteogenesis imperfecta
(Lambert, Masson & Fisch, 2006).
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1.5 MALE FERTILITY AND AGE
The functioning of all body systems declines with age and all are
interconnected, a decline in one system will impact another. For example,
degenerative changes such as a decrease in protein composition and
reduced water content in the prostate affects the quality of semen produced
(Lambert, Masson & Fisch, 2006). DNA damage is significantly higher in
older men as opposed to younger men. The article Male Infertility (2005)
reported that DNA damage was considerably higher in males aged over 45
years than all younger age groups, furthermore, it was doubled in over 45s
when compared to men younger than 30 years of age.

There have been few studies addressing the fertility of older men while
controlling for reduced female fertility. This means the results of such
studies should be interpreted with caution as they may be influenced by
lowered female fertility rather than be associated with male fertility and
advancing age. Testosterone production is known to decline with age
(Lambert, Masson & Fisch, 2006), usually in the sixth decade of life
(Martini, 2001). This is both a variable and gradual process amongst
individuals. While sperm production continues there is a reported decline in
libido and sexual activity (Ng et al., 2004). Slater et al. (2006) notes that,
unlike women, there is no apparent age threshold in relation to sperm
motility however there still appears to be a clear relationship between
advancing paternal age and decreased sperm motility.
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Results of the study by Ng et al. (2004) showed that the median semen
volume and total sperm output reduced significantly in older non-infertile
men (over the age of 50 years). The study also reported that the probability
of obtaining normal values for ejaculate volume, sperm density and total
sperm output was also significantly reduced in older men when compared
with younger men. There was a significant increase in the frequency of
abnormal sperm morphology and vitality especially involving sperm tail
defects observed in this study, which may be a possible reflection of the
complex cellular structural assembly process of the axoneme, resulting in
increased opportunity for age-dependent induced damage (Ng et al., 2004).

Much research has been performed examining the role of antioxidants on
reproduction, however little has been reported specifically on TAG in
relation to age. When looking at ROS and OS a similar picture emerges
where, too few studies have incorporated the added variable of age. Slater
et al. (2006) furthered this by stating that contributions from both the
environment as well as the individuals age and diet are poorly understood.
Clearly there is a need for further examination on such topics and is the
basis for this study.
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2.1 HYPOTHESIS
Advancing age is related to increasing oxidative stress and reduced TAG,
specifically past the age of 40 years.

2.2 AIMS OF THE STUDY
•

The overall aim of the study is to ascertain the relationship between
age and human spermatozoon viability.

•

The specific aim of the study is to determine the relationship
between the effects of ROS, antioxidants and DNA damage on
human spermatozoon viability in relation to age.
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CHAPTER 3:
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3.1 Ethics Approval
Written approval for this study was granted by the King Edward Memorial
Hospital Internal Ethics Committee (EC05-43.1) and by the Edith Cowan
University Faculty of Computing, Health and Science Ethics SubCommittee for the Conduct of Human Research.

3.2 Semen Collection and Processing
Excess semen from samples collected for routine semen analyses or
Assisted Reproductive Technology at Concept Fertility Centre, Subiaco,
were utilized for this study. In total 54 semen samples were collected and
used in the study. Samples were collected through masturbation into sterile
specimen containers. Patient consent for the use of excess semen was
obtained prior to use (refer to Appendix 1 for Consent Form).

A preliminary semen analysis was conducted by Concept staff in
accordance with the World Health Organisation (WHO, 1999) guidelines.
Parameters examined include whole semen volume, pH, consistency,
appearance, concentration, motility and morphology.

Prior to commencement of TUNEL protocol, 5-20JJI of neat sample was
smeared on a silanized glass microscope slide (Superfrost Plus, MenzelGlaser, Braunschweig), air dried and stored until analysis.
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Sample processing was performed at the Concept Fertility Centre. Sample
processing

prior to

commencement

of the

ROS

assay

involved

centrifugation of liquefied semen samples at 300g for 10 minutes in 20m I
Falcon tubes. Seminal plasma was aliquoted into a separate Falcon tube,
later to be transferred to a 2ml microcentrifuge tube and frozen at -SOC until
later required. The pellet was resuspended in PBS, pH 7.4, at a
concentration of 3x1 06 sperm/mi. Tubes containing seminal plasma were
transported on ice to Edith Cowan University, Joondalup. Tubes containing
sperm suspension were transported in a paper bag and kept between 20-

Information was obtained using a semen analysis questionnaire (refer to
Appendix 2) at the time of collection regarding cigarette smoking and
antioxidant supplementation. Ten of the men reported smoking and 4 used
antioxidant supplements. The distribution of these men between the age
groups was equal and so they were included in the study.

3.3 ROS assay
The ROS assay was performed according to the procedure used by Smith
et al (2006). Briefly, basal levels of ROS were will be measured using a
chemiluminescence assay with luminal as the probe. 1O!JI of 5mM stock
luminal in dimethylsulphoxide (DMSO) (refer to Appendix 3 for reagent
preparation) was added to 5001-JI of prepared sperm suspension (refer to
section 3.2). A negative control was prepared by the addition of 1O!JI of
luminal to 5001-JI. of PBS. Results were obtained from sample assessment
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using a luminometer (FLUOstar OPTIMA) and expressed as counted
photons per minute. Samples were processed in such a way as to maintain
a

similar

time

frame

between

centrifugation

and

luminescence

measurement.

3.4 TAC assay
The Total Antioxidant Status Assay Kit, Cat. No. 615700 (Calbiochem) was
utilized for performing the TAC assay. An Eppendorf BioPhotometer was
set at 600nm absorbance and cuvettes (Eppendorf UVette) with a 1 em
path length used. The sample was thawed for 20 minutes at room
temperature. Five minutes prior to use the diluted substrate and chromogen
were equilibrated at 3rC. A Thermomixer Comfort was used to maintain
temperature throughout the assay. A blank sample was prepared according
to Table 1 found in manufacturers protocol (refer Appendix 3). After mixing,
6001-JI of sample was transferred to a cuvette and initial absorbance (Ao)
read. The sample was transferred back into the microcentrifuge tube before
2001-11 of diluted substrate was added. It was mixed again, transferred to a
cuvette and absorbance read at 3 minutes. A standard was prepared (as
per Table 1 in the manufacturers protocol) and processed obtaining an
initial measure and one at 3 minutes. Study samples were then processed
in the same manner as for the blank and standard samples. Antioxidant
concentration was determined following manufacturer's calculation of
antioxidant status found in kit user protocol. The following equation was
used to determine antioxidant levels in each of the samples.
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Antioxidant Concentration (mM) =

[Standard](AA Blank- AA Sample)
(AA Blank- /j.A Standard)

Where

A = absorbance after 3 minutes
A 0 = initial absorbance
AA=A-Ao
[Standard] = concentration of standard (roM)

Two standard and two blank samples were prepared for 15 study samples,
the average was used in the calculation of the antioxidant concentration in
relation to those 15 samples.

3.5 TUNEL assay
This assay was performed using the ApopTag® Plus Peroxidase In Situ
Apoptosis Detection Kit, S71 01 (Chemicon International, Australia). Slides
were fixed with a 3:1 ratio of methanol/acetic acid solution. Slides were then
washed in phosphate buffered saline (PBS) and permeabilised in PBS0.1% Triton X-1 00 solution and washed in PBS. 751-JI Equilibration buffer
was applied for at least 10 seconds and excess removed before 551JI
working strength terminal deoxynucleotidyl transferase (TdT) enzyme was
applied, covered with a plastic coverslip and incubated at 3rC for one
hour. Following this the slide was incubated in working strength stop/wash
buffer and washed in 2 changes of PBS. Anti-digoxigenin peroxidase
conjugate (651JI) was then applied and allowed to incubate at room
temperature for 30 minutes. Slides were washed in PBS then 751JI
p~roxidase

substrate applied and allowed to develop for 4 minutes. When

sufficient colouring had occurred the slides were washed in 3 changes of
dH20 and air dried. Slides were then counterstained using 0.5% (w/v)
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methyl green and washed in dH20 and air dried before being viewed by
brightfield microscopy (1 OOOx magnification). Four hundred sperm were
counted on each slide with DNA damaged sperm being expressed as a
percentage. Sperm with DNA damage were stained brown and undamaged
sperm were stained green (Figure 2). Negative controls were prepared
following the above procedure but reaction buffer was used instead of the
working strength TdT enzyme.

'A
I
L

Figure 2: Pictomicrograph of the TUNEL assay Typical field of view for counting DNA damaged
sperm. 1000x brightfield microscopy. A region of DNA fragmentation can be seen on the sperm
labeled (A). The blue/green stained sperm (L) shows no signs of DNA damage. (Photograph
courtesy of Concept Fertility Centre)

3.6 Statistical Analysis
Univariate analysis was used to assess differences between ROS, TAC,
TUNEL and sperm parameters (motility, morphology, age and total sperm
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concentration).

Independent-group

t-tests

were

performed

in

the

comparison between categorical and continuous variables while the chisquare test for relatedness or independence was performed in the
comparison

of two categorical variables.

Statistical analyses were

performed using the student SPSS for Windows version 15.

Multivariate logistic regression was used for the examination of the
relationships between outcome variables (total sperm concentration,
motility, morphology) and the independent variables ROS, TAC, TUNEL
and age (Appendix 7). An analyses was also performed between age and
the study factors. Possible interactions among the independent variables
included in the regression models were tested and statistical significance
assessed by the Wald Chi-square statistic. The strength of the associations
between variables statistically significantly associated with

outcome

variables in the logistic regression analyses was quantified by estimated
·odds ratios and 95% confidence intervals.
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4.1 Semen Parameters
Semen parameters from samples used in this study are presented in
Table1. Age was grouped into :::;39 yrs and ;;::40 yrs, 16 of the 54 subjects
were ;;::40 yrs age and 38 were :::;39 yrs age. Morphological normality was
considered to be met when ;;::15% of the sample had normal morphology.
The cut off for normal motility was ;;::50%, greater than 50% of the sample
was required to be motile. Total sperm concentration was normal if greater
than 20 million per mi. These cut offs were based on standards according
to the World Health Organisation (WHO, 1999).

Table 1. Semen Variables

:$39 yrs age
Range
:2:40 yrs age
Range

Ejaculate

Total Sperm

Age

Volume

Concentration

Motility

Morphology

(Years)

(mL)

(millionlmL)

(%motile)

(%normal)

32.6 ± 0.6

3.6 ± 0.2

73.7 ± 6.1

62.9 ± 2.1

19.3 ± 1.6

26-39

1.7-6.6

10-175

35.7-93.1

5-39

45.7 ± 1.4

3.8 ± 0.37

79.7 ± 12.4

50.1 ±4.7

20.4 ± 1.4

40-59

1.6- 7.1

18-214

16.7-78.6

14-26

Note: Values are the mean ± SEM and the range

Differences were observed between age groups in relation to mean total
sperm concentration, ;;::40 yrs exhibiting higher sperm counts (79.7±12.4)
than :::;39 yrs (73.7±6.1), and motility, individuals :::;39 displaying higher
motile counts (62.9±2.1) than ;;::40 yrs (50.1±4.7). Conversely, older men
had lower percentage of motility than the younger group.
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Table 2. Studv Factors
ROS

S 39 yrs age
Range
;:: 40 yrs age
Range

Age
(Years)

(counted photons
per minute)

TAC
([AOX] mM)

TUNEL
(% positive)

32.6 ± 0.6
26-39

494.7 ± 151.4
4-5342

2.3 ± 0.14
1.09-6

5.9 ± 0.54
1.35- 13.4

45.7±1.4

408.8 ± 137.2

2.1 ± 0.24

7.7 ± 0.86

40-59

3.5- 1825

0.21-5

3.7- 14.2

Note: Values are the mean ± SEM and the range

4.2 Multivariate logistic Regression Analyses
4.2.1 Age
Multivariate analyses between age, ROS, TAG and TUNEL presented no
statistically significant associations.

Table 3. Results of Multivariate Logistic Regression Analysis Examining
the Relationship between Study Factors and ;::40 yrs age
Waid

study factor

OR*

ROS

TAC

0.8

95%C.I.

Chi-square

df

p-value

0.99- 1.001

0.3

0.6

0.35-1.8

0.3

0.6

0.8

0.4

TUNEL 'normal'
ref: 'abnormal'
~oR: OddsTailo

4.2.1.1 Motility
Statistical significance was observed between motility and age. Analysis
predicts that the odds of displaying abnormal sperm motility are 5.4 times
higher for men ;:::40 years of age than for men :539 years. Statistical
significance was also observed in univariate analysis (Appendix 7) between
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sperm motility and age (p=0.014), men S39 years age displayed higher
counts of motility than those

~40

years age.

Table 4. Results of Multivariate Logistic Regression Analysis Examining
the Relationship between Abnormal Sperm Motility and Study Factors
Wald
study factor

OR*

95%C.I.

Chi-square

1.7

0.99-1.001
0.8-3.6

0.4
1.7

0.6
0.2

3.8

0.7-21

2.4

0.1

5.4

1.2-23.5

5

0.03

ROS
TAC

df

p-value

TUNEL 'normal'
ref: 'abnormal'
Age 'S39'

ref: '0!:40'
*OR: Odds ratio

4.2.2 Sperm Concentration and Morphology
A

statistically significant association was

observed

in

the

sperm

concentration model with DNA damage as measured using TUNEL
(presented in Table 5). Regression analyses predicted that for men with
moderate levels (1 0-14.9%) for DNA fragmentation the odds of having low
sperm concentration (count <20 mill/ml) is 38.7 times that than for men with
_ _ _ ln§ignificant levels {<10%) forpNA fr'!glllentation. The 95% Cl (2.1-727.2)
is very wide and lacking precision which is most likely due to small sample
size.
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Table 5. Results of Multivariate Logistic Regression Analysis Examining the
Relationship between Abnormal Sperm Concentration and Study Factors
Wald
study factor

OR*

95%C.I.

Chi-square

ROS

1.001

0.9- 1.002

1.9

0.2

TAC

1.9

0.5- 7.6

0.9

0.3

38.7

2.06-727.2

5.9

0.02

0.5

0.03-7.3

0.3

0.6

df

p-value

TUNEL 'normal'
ref: 'abnormal'
Age ':539'
ref: '2:40'
*OR: Odds ratio

Table 6. Results of Multivariate Logistic Regression Analysis Examining the
Relationship between Abnormal Sperm Morphology and Study Factors
Wa!d
study factor

OR*

Chi-square

df

p-value

0.99- 1.001

0.001

0.97

1.1

0.5-2.8

0.09

0.8

1.8

0.25- 12.6

0.3

0.6

0.4

0.04-4.1

0.6

0.4

ROS
TAC

95%C.I.

TUNEL 'normal'
ref: 'abnormal'
Age ':'039'
ref: '2:40'

*OR: Odds ratio

Statistically significant mean difference across groups was observed
between total sperm concentration and DNA fragmentation, p<0.001 (refer
to Appendix 7), with men in the

~40

year age group having higher levels of

DNA fragmentation, 7.7±0.86 as opposed to 5.9±0.54. Analyses conducted
using multivariate logistic regression for sperm morphology did not reveai
any significant associations (Tabie 6).
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4.3 Limitations and Bias
Given that associations between ROS, TAC, DNA fragmentation and age
were not observed in this study, it may have been because the statistical
power was limited due to a small sample size of 54. Green (2005) suggests
sample size for regression analyses requires a case:predictor ratio of 10:1
which is also recommended by Peduzzi et al (1996). In wanting to include 4
predictors and assess interaction terms at the very least 4 x 10 cases would
have been required (Peduzzi et al, 1996), and if following recommendations
by Green (1991) then a minimum sample size of 108 would have been
required to assess associations with 4 predictors. For testing the overall
model a minimum sample size of at least 84 would have been required.
This was not possible in the time available for sample collection.

The study samples may have been biased as a result of the method of
collection. All samples were excess samples from routine sperm analysis or
ART. Samples are more likely to exhibit abnormal qualities than samples
that had been collected randomly from the general population and so could
be considered non-representative. The study group

~40

years age was

under-represented.
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5.1 Discussion
Male factor infertility is now recognized as a significant factor for couples
having difficulty conceiving (Agarwal et aL, 2004; Pirrelo et al., 2005;
Tremellen, 2008), particularly with current trends showing couples are
delaying parenthood well into their thirties (Collins & Crosignani, 2005; Ng
et al., 2004). Female fertility has long been established as declining
markedly with age, particularly by the fourth decade of life (Piastira et al.,
2007; Schmid et al., 2007) and it has now become apparent that male
fertility declines with advancing age, albeit not as dramatically as in women
(Slater et al., 2006). There is a growing body of evidence that reactive
oxygen species, total antioxidant capacity and DNA fragmentation play a
very significant role in the aetiology of male infertility. Even though current
research is focusing on the effects of advancing paternal age, few
associations have been definitively established (Nanassy & Carrell, 2008).

Older men are expected to display higher levels of DNA fragmentation
(Aitken & Krausz, 2001) as a result not only of replicative errors but also
from the added effects of oxidative damage over time. If antioxidant
defense mechanisms are lacking there is greater exposure of DNA to ROS
and a greater possibility of ROS induced DNA damage. The study by
Barroso et al. (2000) demonstrated a positive correlation between the
generation of ROS and DNA fragmentation. In the present study men

~40

years exhibited higher levels of DNA fragmentation consistent with previous
reports. Recently a study by Angelopoulou, Plastira and Msaouel (2007)
studied the ageing effects on DNA fragmentation. They observed a
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significant correlation between age and TUNEL positive levels. They
compared 61 oligoasthenoteratozoospermic (OAT) patients, divided into
20-34 year olds and 35-50 year olds, to 49 healthy fertile controls with the

same age group divisions. TUNEL positive results were on average higher
for both patient groups as opposed to the controls with the average of the
35-50 year patient group being significantly higher. Plastira et al (2007)

observed similar findings in their investigation of OAT patients, older
patients with OAT displaying higher levels of DNA fragmentation as
assessed by TUNEL assay.

In the present study the mean value of TAC was lower in the

~40

year age

group compared with the younger group and unexpectedly the mean value
of ROS was higher for the ::539 year age group as opposed to the

~40

year

age group. As Tremellen (2008) notes male factor infertility, regardless of
age, has been linked with oxidative stress by several studies. It is a
combination of both an increase in ROS production and a reduction in TAC.
Moustafa et al. (2004) conducted a study examining the relationship
between ROS and TAC in a group of patients that were randomly selected
from attending a male infertility clinic and a group of controls that were
donors. Moustafa et al. (2004) observed that patients had a significantly
higher ROS level than donors, however they observed no significant
difference of TAC between groups. Another study by Gii-Guzman et al.
(2001) compared ROS and TAC levels in a group of male patients

undergoing infertility screening and a group of normozoospermic donors.
Observations found a significantly lower TAC in patients and a lower mean
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average of ROS levels in donors. Unfortunately these studies did not
examine the relationship of TAG and ROS with paternal age. The above
studies by Moustafa et al. (2004) and Gii-Guzman et al. (2001) involved
only 50 and 48 samples respectively.

Reductions in ejaculate volume, sperm motility and morphology have been
noted with advancing age (Nanassy & Carrell, 2008). Data from the present
study showed an overall reduction in sperm motility in ;:::40 age group
although no relationship with ejaculate volume,

it being or sperm

morphology was observed.

Data collected on the samples from smokers showed comparable readings
of ROS and TUNEL across both groups when compared to those who were
non-smokers. It should be noted however that the TAC values obtained
were not a contributing factor of reduced fertility. Values fell either in the
expected range of 1.3-1.77mM (refer Appendix 4) or higher, indicative of
high seminal plasma antioxidant concentration. The aim of this present
study was to investigate the relationship between age and its influences on
ROS, TAG and DNA fragmentation. The results obtained did not support
the hypothesis that an interaction exists. However associations at a nonsignificant level were observed between age and TAG with statistically
significant findings between motility and age and between total sperm
concentration and DNA fragmentation were found.
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5.2 Future Investigations
Present research is uncovering areas of significant concern with regard to
male infertility. Links between DNA fragmentation and advancing age
resulting in sub fertility have been well documented (Aitken & Krausz, 2001;
Barroso et al., 2000; Lambert, Masson & Fisch, 2006; Moustafa et al.,
2004).

Reactive oxygen species, particularly when associated with

oxidative stress, have been shown to increase the level of DNA damage
found in spermatozoa (Barroso et al., 2000; Donnelly et al., 1999; Lambert,
Masson & Fisch, 2006) and when using standard analyses is not
necessarily readily identifiable. Furthermore, total antioxidant capacity is
associated with both ROS and DNA damage (Baker & Aitken, 2005;
Sanocka & Kurpisz, 2004; Tremellen, 2008) where it only exacerbates the
problem. Conclusive evidence needs to be established in linking these
factors to reduced male fertility particularly concerning advancing age with
the potential range of benefits falling anywhere between higher success
rates with ART procedures of IVF and ICSI to a reduction in the incidence
of childhood disorders resulting from germ line aberrations.

5.3 Conclusion
Susceptibility of spermatozoa to oxidative stress is intensified by the
capacity for them to produce ROS themselves. Oxidative stress, resulting
from excess reactive oxygen species generation and reduced total
antioxidant capacity, not only appears to disrupt the fertilizing capacity of
the sperm but also to attack both nuclear and mitochondrial DNA. The
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ability of an embryo to both repair this damage and survive to term appears
to be negatively associated with the level of DNA fragmentation in the germ
line of spermatozoa. Natural protective mechanisms exist to prevent
spermatozoa with damaged genomes from participating in the fertilization
process however with the advent of ICSI these barriers can be bypassed
resulting in a higher incidence of poor pregnancy outcomes and even
childhood disease. This highlights the importance of further identifying
significant interactions between age and other factors such as ROS, TAC
and DNA damage implicated in the aetiology of male factor infertility.
Benefits of this approach wol.lld enable a more individual diagnosis and
treatment and have the potential to reduce the transmission of childhood
diseases at the genomic level.
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7.1 Appendix 1
Consent Form
BACKGROUND
Concept Fertility Centre would like to use some of your sperm for a research
project. Normally, only a portion of your sperm is used for a semen analysis or
ART preparation and the remainder is discarded. We would like to use this
surplus sperm to study the effects of age on sperm quality. The causes of male
infertility include genetic problems, chromosome abnormalities, infectious
diseases, blockages, radiation, chemotherapy and erectile dysfunction. It is well
documented that older men take longer to produce pregnancy with an increasing
proportion undergoing assisted reproduction. Recent research has focused on the
effects of oxidative stress on human sperm quality. Normal sperm production
requires a balance between reactive oxygen species and antioxidants.
Imbalances can cause oxidative stress to occur which can have a significant effect
on normal human sperm function. This research will provide us with valuable
information that will increase our knowledge of the factors that effect sperm
function and may therefore benefit couples with male factor infertility. Your sample
will not be identifiable in this research.

1. ................................................................................................. have
(Given Names)
•

(Surname)

read the information above explaining the study entitled
age on human sperm oxidative stress"

"The effects of

I have read and understood the information given to me. Any questions I
have asked have been answered to my satisfaction. I agree to allow my
sperm to be used for this research.
•

I agree that research data gathered from the results of this study may be
published, provided that names are not used.

•

I am aware that I may withdraw this consent at any time, in writing to the
Scientific Director.

If you have any complaints regarding the conduct of this study please refer them to
Dr Geoff Masters, Director of Clinical Services, who can be contacted on
9340 8222.
Dated ................... day of ..................... 20 ....... .
Signature ............................................. .
I, ..................................... have explained the above to the signatory who has
(Investigators full name)
stated that he understood the same.

Signature ...................................... .
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7.2 Appendix 2
Semen Analysis Questionnaire
Please take a few minutes to complete these questions. Your answers will help us
interpret your semen analysis results.
1.

Is the sample jar labeled with YOUR name and date of birth?
Please circle the correct answer
Yes
No

2.

What time did ejaculation occur?

3.

Did you collect the whole ejaculate?
Please circle the correct answer
If no -what portion was missed
end

Yes

No

first

middle

4.

How many days has it been since your last ejaculation?

5.

Have you suffered from any illness in the last 3 months that raised your
body temperature?
Please circle the correct answer
Yes
No
Comments: ............................................................................... .

6.

Have you taken any medications during the last 3 months?
Please circle the correct answer
Yes
No
Comments: ................................................................................

7.

Have you taken any antioxidant dietary supplementation during the last 3
months?
Please circle the correct answer
Yes
No

If yes please indicate the type and dosage .................................... .

8.

Have you smoked cigarettes during the last 3 months?
Please circle the correct answer
Yes

No

If yes please indicate the number per day ...................................... .
Name:

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Signature: .................................... .

*·Please place the completed questionnaire in the paper bag with your
sample jar and take to the collection cupboard.*
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7.3

Appendix 3

ROS Assay Reagent Preparation

Dimethylsulphoxide (DMSO) Fw: 78.13
Luminol Fw: 177.16

1. Weigh out 0.468g ofLuminol.
2. Add 1.3ml ofDMSO to produce a 2M stock Luminol in DMSO solution.
3. Aliquot 25 J.Ll of stock luminol in DMSO into a sterile 2ml microcentrifuge.
4. Add 975J.Ll ofDMSO to produce a 5mM working strength Luminol in
DMSO solution.
5. DMSO was stored wrapped in aluminium foil due to its light sensitivity.
6. Stock and working strength solution was made freshly daily.
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7.4

Appendix 4

TAC Kit User Protocol (Calbiochem)

Visit our Interactive Pathways rr.t at
www.calbiochem.com/pathways

Calbiochem®
User Protocol 615700 Rev. 20-July-06 JSW

Total Antioxidant Status Assay Kit
Cat. No. 615700

Note that this user protocol is not lot-specific and is representative of the current
specifications for this product. Please consult the vial label and the certificate of analysis
for information on specific lots. Also note that shipping conditions may differ from storage
conditions. Full details are available at www.calbiochem.com.

Size
1 kit
Form
50 Tests.
Format
Cuvette
Detection Method
Colorimetric
Storage
Upon arrival store the entire kit contents at 4°C. Note: The concentration of the
standard is lot-specific. Please refer to the vial label for lot-specific concentration.
Intended Use
The Calbiochem® Total Antioxidant Status Assay Kit is designed to assay antioxidant
levels in serum or plasma samples. Additionally, the assay may be used to measure the
antioxidant potential of (suitably solubilized) food and drug samples.
Background
Free radicals are highly reactive molecules generated by the biochemical redox reactions
that occur as part of normal cell metabolism, and by exposure to environmental factors
such as UV light, cigarette smoke, environmental pollutants and gamma radiation . Once
formed , free radicals attack cell structures in the body. As a result, free radicals have been
implicated in numerous diseases, including cancer, atherosclerosis, rheumatoid arthritis,
diabetes, liver damage, and central nervous system disorders.
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Principle of the Assay
The Total Antioxidant Status Kit is dependent on antioxidants in the sample inhibiting the
oxidation of ABTS™ (2,2'-Azino-di-[3-ethylbenz-thiazoline sulphonate]) substrate to
ABTS™•+ product by metmyoglobin (a peroxidase). The amount of ABTS™•+ product can
be monitored by reading the absorbance at 600 nm. Under the reaction conditions used,
the antioxidants in the sample cause suppression of the absorbance at 600 nm to a degree
that is proportional to their concentration.

Figure 1: Principle of the Assay

HX-Fe 3+

....

+

metmyoglobin

l

· X-[Fe 4+ =0] + ABTS
ferrylmyoglobin
+Antioxidants/
Reaction inhib~ed '

less A8TS .+
produced

~Antioxidants

ABTS . ++ HX-Fe 3+
(Read at 600 nm)

Materials Provided
• Buffer: 1 bottle, 100 ml, Phosphate Buffered Saline
• Chromogen: 5 vials, 10 ml each, Metmyoglobin and ABTS™
• Substrate: 2 vials, 5 ml each, stabilized HzOz
• Standard: 5 vials, 1 ml each, 6-Hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid*
*The concentration of the standard is lot specific. Please consult the vial label for
the concentration.
Materials Required but not Provided
• Spectrophotometer or automated analyzer capable of measuring absorbance at 600 nm.
A temperature controlled cuvette holder is highly recommended.
• Cuvettes with 1-cm path length
Precautions and Recommendations
• AI! pipettes should be thoroughly cleaned before use. Water used in the assay must be
as pure as possible, the minimum standard being double-deionized water.
• Ensure that all pipettes have been accurately calibrated and are dispensing the correct
volume.
• Ensure that all glassware and disposables are free from contamination, especially from
hypochlorite and detergents.
• Check the temperature of the equipment being used for incubation of the samples.
• Time the reaction carefully. The absorbance changes very rapidly, and any delay in
taking the reading can lead to a substantial error.
• Ensure that there has been no loss of standard material upon opening the vial. The
standard is supplied in lyophilized form, and the vials are, therefore, under vacuum. The
stopper must be removed slowly to allow air to enter the vial gradually; otherwise there is a
risk that material will be lost. In addition, before the stopper is fully removed, the bottle
should be sharply tapped on the bench several times to dislodge any material adhering to
the stopper. The stopper should then be removed and placed flat side down on the bench
while the appropriate volume is dispensed into the vial for reconstitution. The stopper
should then, be replaced and the contents mixed, ensuring that the liquid comes into
contact with the stopper, so that any material adhering to the stopper is dissolved.
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Reagent Preparation
• Chromogen: Add 10 ml Buffer to each vial of Chromogen needed for the assay (10 tests
per vial). After reconstitution, the Chromogen is stable for 2 days at 4°C or 8 h at room
temperature.
• Substrate: Dilute each vial of Substrate needed for the assay by adding 7.5 ml Buffer.
After dilution, the substrate is stable for 24 hat 4°C. NOTE: Some automated methods do
not require substrate dilution.
• Standard: Add 1 ml distilled water to each vial of Standard needed for the assay. After
reconstitution, the Standard is stable for 2 days at 4°C or 1 month at -20°C.
Detailed Protocol
1. Zero the spectrophotometer at 600 nm against air and set temperature to 3rC.
Equilibrate the diluted Substrate and Chromogen at 3rC for 5 min just prior to use. NOTE:
It is advisable to equilibrate only the amount of each reagent necessary for the assays to
be performed. A temperature of 3rC must be maintained throughout the assay.
2. Add the following to a cuvette:

Table 1: Addition of Reagents

ddH 20
Standard
Sample
Chromogen

Blank
20

STANDARD

SAMPLE

20
lml

20
lml

lml

3. Mix well and read the initial absorbance {Ao)
4. Add 200 IJI diluted Substrate to each cuvette. Mix and start the timer simultaneously.
5. Read the absorbance after exactly 3 min (A)

Calculations
Calculation of Total Antioxidant Status
The antioxidant concentration of the Standard is used to calculate the antioxidant levels in
the samples.
1. Determine the ll.A for the samples, standard, and blank. ll.A A - Ao
2. Calculate the concentration of antioxidants in the sample using the formula below:

=

Figure 2: Antioxidant Concentration Formula
Antioxidant Con•:::enlration (mM) ==

[Standard] (I:!. A Blank -!:.A Sample)

•:/).A Blank -l:!.A Standard:•

NOTE: If the antioxidant concentration is greater than 2.5 mM dilute the sample with 0.9%
NaCI andre-assay. Typical antioxidant levels in normal human plasma are 1.30-1.77 mM.
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Sensitivity
Typically serum or plasma samples of 20 1-11 are sufficient when using the manual
method. Samples of 5 IJI are typically sufficient when using an automated
analyzer. The assay is linear for antioxidant levels less than 2.5 mM.
Assay Range
0-25 nmol/1 0 IJI plasma
Precision
Intra-assay coefficient of variation= 1.2% (mean= 1.37 mM; n = 20)
Inter-assay coefficient of variation = 2.4% (mean = 1.35 mM; n = 18).
Toxicity
MSDS available upon request.
References
Miller, N.J., et al. 1993. Clin. Science 84,407.
Trademarks
Calbiochem® is a registered trademark of EMD Biosciences, Inc.
ABTS™ is a trademark of Roche Diagnostics

Prices and availability are subject to change. ©Copyright 2006 EMB Biosciences, Inc., an affiliate of Merck KgaA, Darmstadt,
Germany. All rights reserved. Each product is sold with a limited warranty, which is provided with each purchase. Each product is
intended to be used for research purposes only. It is not to be used for drug or diagnostic purposes, nor is it intended for human
use. EMD Biosciences products may not be resold, modified for resale, or used to manufacture commercial products without
written approval of EMD Biosciences.

USA and Canada

Germany

United Kingdom and Ireland

Tel (800) 628-8470
t?chnicai((:DcalbiocheJn.cq

Freephone 0800 100 3496
techservice@merckbiosciences.
de

UK Freephone 0800 622935
Ireland Toll Free 1800 409445
techservice@merckbiosciences.co
.uk

m

All Other Countries
Contact Your Local
Distributor
www.calbiochem.com
technical@calbiochem.co

m
A Brand of EMD Biosciences, Inc., an Affiliate of Merck KGaA, Darmstadt, Germany
www.calbiochem.com

FOR RESEARCH USE ONLY. NOT FOR HUMAN OR DIAGNOSTIC USE.
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7.5 Appendix 5
Protocol for TUNEL Assay using Apoptag kit and Grading
System

DNA Fragmentation in Sperm using Apoptag kit

Making slides for DNA fragmentation staining
1. Etch a circle (approx 25mm diameter) on the back of 2 Superfrost Plus slides with a
diamond pen. 1 of the slides will be used for staining and the 2nd a spare, unless
used as a negative.
2. Write the patients identification number and date in pencil on the front of the slide.
3. Smear the appropriate volume of semen (see below) with the side of a pipette tip
onto the front of the slide within the circle.
For sperm counts > 40 mill/ml use 5~1
For sperm counts 10-40 mill/ml use 10~1
For sperm counts 5-10 mill/ml use 20~1
For sperm counts < 5 mill/ml perform a spin direct on 1-2 ml of semen and
use 20~1
4. Allow slides to dry.

Staining Slides

1. Remove 2 slides per patient from the slide box and place in a coplin jar containing
40 ml methanol/acetic acid (3:1 ratio) for 5 minutes at room temp.
2. Wash in PBS for 5 mins.
3. Permeabilise cells by incubating in PBS-0.1% Triton X-1 00 for 5 mins.
4. Wash in PBS 2 times for 5 mins. Remove equilibration buffer, Reaction buffer and
Stop/Wash buffer concentrate from freezer. Remove TdT enzyme from freezer just
prior to use.
5. Apply equilibration buffer to slides

(75~1/5cm2)

and incubate at room temp for at

least 10 seconds.
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While this is incubating make up working strength TdT enzyme by adding

77~1

Reaction buffer to 33~1 TdT enzyme (enough for 2 slides).
6. Blot excess equilibration buffer off the slide and apply working strength TdT enzyme
(55~1/slide)

and cover with a plastic coverslip ..

7. Place in 3rC incubator for 1 hour. During this incubation make up the Stop/Wash
buffer by adding 1ml concentrate to 34m I of dH20 in a coplin jar.
8. Remove coverslips carefully from slides and incubate in Stop/Wash buffer for 10
mins.
9. Wash slides in 2 changes of PBS for 5 minutes each in a coplin jar.
10. Blot off excess liquid and apply room temperature Anti-Digoxigenin Peroxidase
conjugate (65~1/5cm2). Incubate in a humidified chamber at room temp for 30 mins.
11. Wash slides in 2 changes of PBS for 5 mins each in a coplin jar. Make up
Peroxidase substrate by adding

147~1

DAB dilution buffer to

3~1

DAB substrate for

every 2 slides. WARNING! DAB is a carcinogen. Handle with gloves and dispose of
all waste into yellow biohazard bags!!
12. Stain in substrate

(75~1/slide)

for 4 minutes at room temp, stopping reaction by

washing in 3 changes of dH20 at room temp. Airdry slides.
13. Counterstain slides in Methyl Green (0.5%) solution for 10 mins, followed by
washing in 2 changes of dH20 (3 quick dips each).
14. Airdry slides before viewing under microscope (100x oil immersion lens).
15. Count at least 400 sperm per slide and record results.

Sperm DNA Fragmentation grading

Less than 10% : Insignificant level
10-14.9%: Moderate level
15 - 19.9% : Significant level
More than 20% : Severe level
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7.6 Appendix 6
TUNEL Assay Reagent Preparation
10X Phosphate Buffered Saline, pH 7.4 (PBS)
1. Dissolve 55g of NazHP04, 13.5g of NaHzP04 and 117g of NaCI in
800ml of dH20.
2. Adjust pH to 7.4 using NaOH or HCI.
3. Fill to a final volume of 1L using dHzO.

PBS-0.1% Triton X-1 00
Mix 1ml of Triton X-1 00 concentrate to 99ml of PBS, pH 7 .4. Store at 4 oc
for up to 1 month.

Working Strength TdT Enzyme
331JI of TdT enzyme was added to 771-11 of Reaction buffer. Quantity
sufficient for the treatment of two 5cm 2 slides.
Both reagents are components of the Apoptag® Plus Peroxidase In Situ
Apoptosis Detection Kit, S71 01.

Working Strength Stop/Wash buffer
1ml of Stop/Wash concentrate was mixed with 34ml of dH 2 0. Quantity
sufficient to treat 5 slides in a coplin jar.
Stop/Wash buffer comes as a component of the Apoptag® Plus Peroxidase

In Situ Apoptosis Detection Kit, S71 01.

Peroxidase Substrate
Mix 31JI of 50X DAB substrate with 1471JI of 1X DAB dilution buffer. Quantity
sufficient to treat two 5cm 2 slides.
Both reagents are components of the Apoptag® Plus Peroxidase In Situ
Apoptosis Detection Kit, S71 01.
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0.5% Methyl Green Stain
1. Dissolve 1.36g of Sodium Acetate (C2H302Na·3H 20) in 80ml dH 20.
Adjust pH to 4 using acetic acid and make up to 1OOml using dH 20
to produce a 0.1 M Sodium acetate solution.
2. Dissolve 0.5g of Methyl green (crystal violet free, Sigma-Aldrich,
M8884) in 100ml Sodium Acetate solution.
3. Filter through either a 0.45J.Jm or 0.2J.Jm filter.
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7.7 Appendix 7
Results Univariate Models
Table 1 Univariate Analvses for Total Soerm Count
Total Sperm Count
Abnormal
%

Total Sperm Count Normal
%

Test for
association
p-value

ROS

7.4a

92.6°

0.119*

TAC

7.5 8

92.5c

0.975*

Study variables

Tunel:

normal

97.7e
66.79

0.001**

abnormal
Age category:
years

2.3°
33.3f

::; 39

7.91
6.3d

92.1n
93.8i

0.833**

Sperm Morphology
Abnormal
% (n)

Sperm Morphology Normal
% (n)

Test for
association
p-value

ROS

21.2 8

78.8b

0.958*

TAC

21.2 8

78.8b

Tunel:
normal

20c

80e

28.6d

71.4c

24
12.5h

76 9
87.5 8

2:40

years

a
0
c
a
e
I
n sample number of analys1s =4 =50 =49 =1 =43 =3 9=6 =35 =15
* T test for mean difference across groups
** Chi-squared test for association

Table 2. Univanate Ana1vses f or sioerm Moro1h o Io lV
Study variables

abnormal
Age category: ::; 39
years
2:40
years

I

0.995*
0.628**

0.489**

a
D
c .a
g
e
n sample number of analysis =7 =26 =5 =2 =20 =6 =19 =1
• T test for mean difference across groups
•• Chi-squared test for association

T abl e 3 Umvanate A na•vses f or s;perm M0 tTt
I ltV
Sperm Motility Abnormal
% (n)

Sperm Motility Normal
% (n}

Test for
association
p-value

ROS

12.28

77.8°

0.690*

TAC

22.6 8

77.4c

0.610*

18.2u
44.4f

81.8 9
55.69

0.086**

13.29
43.8i

86.8n
56.3j

Study variables

Tune!:
abnormal
Age category:
years

normal

s 39
2:40

0.014**

years

aD
c
a
e
g
I
n sample number of analysis -12
=42 =41 =8 =36 =4 =5 =33 =7 J=9
• T test for mean difference across groups
•• Chi-squared test for association
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Table 4. Univariate Analvses for Aae
:!5 39 years
o/o (n)

Study variables

~

40 years
o/o (n)

Test for
association
p-value

ROS

70.4a

29.6°

0.733*

TAC

69.8c

30.2°

0.416*

72.7a
55.6f

27.3e
44.49

0.307**

Tunel:
abnormal

normal

g
e
a .D
c .a
n sample number of analysis =38 =16 =37 =32 =12 =5 =4
• T test for mean difference across groups
•• Chi-squared test for association
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